Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic sidesteps whistleblower suit

This article was originally published in The Gray Sheet

Executive Summary

Gilligan v. Medtronic dismissed by U.S. Court of Appeals for the Sixth Circuit because the plaintiff's grounds for allegations were publicly disclosed already and thus exempt from the False Claims Act, Washington Legal Foundation reports April 13. WLF had filed a brief supporting Medtronic and urging dismissal on the grounds that the Supreme Court's 2001 Buckman decision precluded all fraud-on-FDA claims. Attorneys Louis Gilligan and Gregory Utter attempted to sue Medtronic on behalf of the U.S. government, citing malfunctions with two pacemaker leads that have been off the market for more than a decade...

You may also be interested in...



ICH Syncs Reproductive Toxicity Guidance With Current Science

The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.

Stada Grabs GSK Brands In EU

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 
UsernamePublicRestriction

Register

MT021991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel